These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 36525924)
21. Serine Protease HtrA2/Omi Deficiency Impairs Mitochondrial Homeostasis and Promotes Hepatic Fibrogenesis via Activation of Hepatic Stellate Cells. Hur W; Kang BY; Kim SM; Lee GW; Kim JH; Nam MK; Rhim H; Yoon SK Cells; 2019 Sep; 8(10):. PubMed ID: 31547195 [TBL] [Abstract][Full Text] [Related]
22. THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death. Balakrishnan MP; Cilenti L; Mashak Z; Popat P; Alnemri ES; Zervos AS Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H643-53. PubMed ID: 19502560 [TBL] [Abstract][Full Text] [Related]
23. The protease Omi regulates mitochondrial biogenesis through the GSK3β/PGC-1α pathway. Xu R; Hu Q; Ma Q; Liu C; Wang G Cell Death Dis; 2014 Aug; 5(8):e1373. PubMed ID: 25118933 [TBL] [Abstract][Full Text] [Related]
24. Neurodegeneration in mnd2 mutant mice is not prevented by parkin transgene. Yoshida T; Mizuta T; Shimizu S Biochem Biophys Res Commun; 2010 Nov; 402(4):676-9. PubMed ID: 20971077 [TBL] [Abstract][Full Text] [Related]
25. Serine protease HtrA2/Omi regulates adaptive mitochondrial reprogramming in the brain cortex after ischemia/reperfusion injury via UCP2-SIRT3-PGC1 axis. Meng H; Sun LK; Su J; Yan WY; Jin Y; Luo X; Jiang XR; Wang HL Hum Cell; 2022 Jan; 35(1):63-82. PubMed ID: 34807408 [TBL] [Abstract][Full Text] [Related]
26. HtrA2 deficiency causes mitochondrial uncoupling through the F₁F₀-ATP synthase and consequent ATP depletion. Plun-Favreau H; Burchell VS; Holmström KM; Yao Z; Deas E; Cain K; Fedele V; Moisoi N; Campanella M; Miguel Martins L; Wood NW; Gourine AV; Abramov AY Cell Death Dis; 2012 Jun; 3(6):e335. PubMed ID: 22739987 [TBL] [Abstract][Full Text] [Related]
27. Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease. Unal Gulsuner H; Gulsuner S; Mercan FN; Onat OE; Walsh T; Shahin H; Lee MK; Dogu O; Kansu T; Topaloglu H; Elibol B; Akbostanci C; King MC; Ozcelik T; Tekinay AB Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18285-90. PubMed ID: 25422467 [TBL] [Abstract][Full Text] [Related]
28. The role of PARL and HtrA2 in striatal neuronal injury after transient global cerebral ischemia. Yoshioka H; Katsu M; Sakata H; Okami N; Wakai T; Kinouchi H; Chan PH J Cereb Blood Flow Metab; 2013 Nov; 33(11):1658-65. PubMed ID: 23921894 [TBL] [Abstract][Full Text] [Related]
30. N-terminal truncation circumvents proteolytic degradation of the human HtrA2/Omi serine protease in Escherichia coli: rapid purification of a proteolytically active HtrA2/Omi. Seong YM; Park HJ; Seong GH; Choi JY; Yoon SJ; Min BR; Kang S; Rhim H Protein Expr Purif; 2004 Feb; 33(2):200-8. PubMed ID: 14711507 [TBL] [Abstract][Full Text] [Related]
31. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases. Goo HG; Rhim H; Kang S Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693 [TBL] [Abstract][Full Text] [Related]
32. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease. Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332 [TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Fitzgerald JC; Camprubi MD; Dunn L; Wu HC; Ip NY; Kruger R; Martins LM; Wood NW; Plun-Favreau H Cell Death Differ; 2012 Feb; 19(2):257-66. PubMed ID: 21701498 [TBL] [Abstract][Full Text] [Related]
34. MLF1 is a proapoptotic antagonist of HOP complex-mediated survival. Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643 [TBL] [Abstract][Full Text] [Related]
35. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi. Liu MJ; Liu ML; Shen YF; Kim JM; Lee BH; Lee YS; Hong ST Biochem Biophys Res Commun; 2007 Oct; 362(2):295-300. PubMed ID: 17707776 [TBL] [Abstract][Full Text] [Related]
36. The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Hartkamp J; Carpenter B; Roberts SG Mol Cell; 2010 Jan; 37(2):159-71. PubMed ID: 20122399 [TBL] [Abstract][Full Text] [Related]
37. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. Kawamoto Y; Kobayashi Y; Suzuki Y; Inoue H; Tomimoto H; Akiguchi I; Budka H; Martins LM; Downward J; Takahashi R J Neuropathol Exp Neurol; 2008 Oct; 67(10):984-93. PubMed ID: 18800009 [TBL] [Abstract][Full Text] [Related]
38. Mitochondrial serine protease Omi/HtrA2 accentuates brain ischemia/reperfusion injury in rats and oxidative stress injury in vitro by modulating mitochondrial stress proteins CHOP and ClpP and physically interacting with mitochondrial fusion protein OPA1. You H; Jin Y; Kang J; Mao Y; Su J; Sun L; Wang L; Meng H Bioengineered; 2020 Dec; 11(1):1058-1070. PubMed ID: 33016225 [TBL] [Abstract][Full Text] [Related]